NAGS deficiency should be considered within the differential diagnosis for patients with 3‐MGA where a proximal urea cycle disorder is suspected; a trial of carglumic acid should be initiated if active management is being pursued. The gene discussed is NAGS; the disease is urea cycle disorder.